Who we are.
EVER Pharma is a fully integrated specialty pharmaceuticals company focused on the research, development, production, and commercialization of products in the areas of neurology and specialty injectables, covering oncology, intensive care and hormone therapeutics.
From our headquarters in Austria, we run a dynamic operation providing innovative products and value-added formulations aimed at enhancing the lives of patients and supporting the work of healthcare professionals through improved convenience and safety.
Our products are developed and manufactured at our EU GMP certified facilities in Austria and Germany. These are highly specialized in the production of complex injectables including high potency and controlled substances, crystal suspensions, as well as oily solutions in vials, pre-filled syringes, cartridges, implants, and ampoules.
We market our products in more than 70 countries around the world through our own international affiliates and strategic partners.
Competence through expertise.
Through dedicated research, focus on highly specialized therapeutic areas and an international outlook, we have established a solid platform that enables us to make a considerable contribution to healthcare systems around the world.
Opening of new production and research site in Jena.
EVER Pharma invests over €200 million in state-of-the-art injectable manufacturing facilities in Jena.
EVER Pharma GmbH acquires the injectable manufacturing facility of Novartis in Jena, Germany and establishes EVER Pharma Jena GmbH.
EBEWE Pharma is divided into two separate businesses – neurology and oncology. The oncology business is divested to Novartis and the neurology business is spun off and rebranded as EVER Pharma GmbH.
EBEWE Pharma becomes a privately held pharmaceutical company through a management buy-out.
EBEWE Pharma becomes part of BASF group of companies and then briefly part of ABBOTT (US).
EBEWE Pharma relocates to Unterach, Austria.
EVER Pharma is founded under the name of “EBEWE Pharma” in Vienna, Austria.
Facts & Figures.
The EVER Group was founded in Austria in 1934.
Headquarters & Production sites
EVER Pharma is headquartered in Unterach, Austria with production and research facilities in Austria, Germany, and the US.
EVER Pharma markets high-quality products in over 70 countries worldwide through its own representative offices and sales partners.
Number of employees
Over 1,000 employees worldwide.
Research & Development
EVER Pharma invests around €25 million annually in R&D.
EVER Pharma specializes in the areas of neurology and specialty injectables, including oncology, intensive care and hormone therapeutics.
Authority audits / certifications
ISO 13485, ISO 16247, ISO 14001, EU-GMP, GCC (MENA), CFDA (China), ANVISA (Brazil), RU-GMP, PDMA (Japan)